Latest Breaking News On - Study may proceed - Page 1 : comparemela.com

Intensity Therapeutics Provides Business Update Reflecting Progress in Phase 3 Sarcoma Program

FDA provides Study May Proceed letter for open-label, randomized phase 3 protocol in soft tissue sarcoma, and plans to initiate phase 3 study in first half of 2024 SHELTON, Conn., Jan. 3, 2024.

United statesMerck sharpe dohmeJonathan nugentDavid rosenLewish benderBristol myers squibbChristian frederick meyerCompany nasdaqOttawa hospital research instituteOffice of orphan products developmentDrug administrationPrnewswire intensity therapeutics incOntario institute of cancer researchCompanya study mayIntensity therapeutics incInvestigational new drug

Alzamend Neuro Receives FDA Study May Proceed Notification for a Phase IIA Clinical Trial of AL001, a Next‑Generation Lithium Therapeutic Drug Candidate, in Post-Traumatic Stress Disorder Patients | Region

ATLANTA (BUSINESS WIRE) Dec 11, 2023

United statesStephan jackmanSecurities exchangeAlzamend neuro incExchange commissionAmerican psychiatric associationDrug administrationUniversity of south florida research foundation incChief executive officerStudy may proceedNew drug applicationMayo clinicSouth florida research foundationSecurities actSecurities exchange actAlzamend neuro

Carisma Therapeutics (CARM) Announces FDA Clearance of IND Application for CT-0525

Carisma Therapeutics (CARM) Announces FDA Clearance of IND Application for CT-0525
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

Steven kellyMichael klichinskySociety for immunotherapy of cancer annual meetingCarisma therapeutics incDrug administrationCarisma therapeuticsInvestigational new drugStudy may proceedChief executive officerAnnual meetingChief scientific officer

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte

Carisma Therapeutics Announces FDA Clearance of IND Application for CT-0525, a Novel HER2-Targeting CAR-Monocyte
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

United statesMichael klichinskySteven kellySociety for immunotherapy of cancer annual meetingExchange commissionCarisma therapeutics incCompany quarterly report on formPrnewswire carisma therapeutics incDrug administrationInvestigational new drugStudy may proceedChief executive officerAnnual meetingChief scientific officerPrivate securities litigation reform actQuarterly report

Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update

Arvinas Reports Third Quarter 2023 Financial Results and Provides Corporate Update
streetinsider.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from streetinsider.com Daily Mail and Mail on Sunday newspapers.

San antonioUnited statesJohn houstonKirsten owensOerth bioJeff boyleEuropean society for medical oncology congressDevelopment expensesArvinas incAccess pathway steering groupPfizer incExchange commissionThird quarter businessEuropean societyMedical oncology congressStudy may proceed